Filing Details

Accession Number:
0001415889-21-003035
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-16 18:31:52
Reporting Period:
2021-06-14
Accepted Time:
2021-06-16 18:31:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604821 Natera Inc. NTRA Services-Medical Laboratories (8071) 010894487
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1711968 Leonard Steven Chapman C/O Natera, Inc.
13011 Mccallen Pass Building A Suite 100
Austin TX 78753
Ceo And President No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-14 26 $10.73 78,582 No 4 M Direct
Common Stock Acquisiton 2021-06-14 2,289 $9.29 80,871 No 4 M Direct
Common Stock Acquisiton 2021-06-14 1,563 $13.01 82,434 No 4 M Direct
Common Stock Acquisiton 2021-06-14 7,813 $13.01 90,247 No 4 M Direct
Common Stock Acquisiton 2021-06-14 1,563 $20.27 91,810 No 4 M Direct
Common Stock Acquisiton 2021-06-14 4,688 $25.46 96,498 No 4 M Direct
Common Stock Disposition 2021-06-14 8,846 $103.15 87,652 No 4 S Direct
Common Stock Disposition 2021-06-14 9,096 $103.83 78,556 No 4 S Direct
Common Stock Disposition 2021-06-14 3,041 $103.41 75,515 No 4 S Direct
Common Stock Disposition 2021-06-14 5,109 $104.15 70,406 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2021-06-14 26 $0.00 26 $10.73
Common Stock Stock Option (right to buy) Disposition 2021-06-14 2,289 $0.00 2,289 $9.29
Common Stock Stock Option (right to buy) Disposition 2021-06-14 1,563 $0.00 1,563 $13.01
Common Stock Stock Option (right to buy) Disposition 2021-06-14 7,813 $0.00 7,813 $13.01
Common Stock Stock Option (right to buy) Disposition 2021-06-14 1,563 $0.00 1,563 $20.27
Common Stock Stock Option (right to buy) Disposition 2021-06-14 4,688 $0.00 4,688 $25.46
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
77 2027-07-13 No 4 M Direct
34,341 2028-03-08 No 4 M Direct
44,271 2029-01-10 No 4 M Direct
54,687 2029-01-10 No 4 M Direct
50,521 2029-04-11 No 4 M Direct
32,812 2030-03-26 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2021, as amended on May 14, 2021.
  2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.54 to $103.53 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.56 to $104.23 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.85 to $103.79 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.8450 to $104.46 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. The option shares are fully vested and may be exercised at any time.
  7. The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter.
  8. The option shares vest over four years. 25% of the option shares vested and became exercisable on January 2, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
  9. This option vested and became exercisable upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price. As of March 9, 2021, the criteria was satisfied with respect to the remaining 31,250 shares
  10. The option shares vest over four years. 25% of the option shares vested and became exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
  11. The option vests upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price. As of June 3, 2021, the Company's Board of Director determined the performance criteria had been met with respect to 18,750 additional shares.